Investor Resources

As leading experts in home-based respiratory care and disease management, we are dedicated to helping patients breathe better and live longer, healthier lives.

Investor Resources

As leading experts in home-based respiratory care and disease management, we are dedicated to helping patients breathe better and live longer, healthier lives.

News and Events

Events

2022

3 November 2022

2022 Third Quarter Earnings Conference Call

4 August 2022

2022 Second Quarter Earnings Conference Call

4 May 2022

2022 First Quarter Earnings Conference Call

2021

2 November 2021

2021 Year End Earnings Conference Call

2 November 2021

2021 Third Quarter Earnings Conference Call

3 August 2021

2021 Second Quarter Earnings Conference Call

4 May 2021

2021 First Quarter Earnings Conference Call

3 March 2021

2020 Year End Earnings - Conference Call

2020

5 November 2020

2020 Third Quarter Earnings Conference Call

5 August 2020

2020 Second Quarter Earnings Conference Call

5 May 2020

2020 First Quarter Earnings Conference Call

3 March 2020

2019 Year End Earnings - Conference Call

Investor Relations Presentation and Downloads

Presentation Deck and Fact Sheet

The following information was accurate at the time of posting but may be superseded by subsequent disclosure. 

Quarterly and Conference Calls

Viemed hosts quarterly earning calls. All replays will be posted following calls.

Corporate Governance

Viemed Healthcare follows and maintains high standards of Corporate Governance. The Board of Directors of Viemed Healthcare believes that good governance practices protect long-term shareholder value and ensure that the Company conducts its activities and operations with integrity and in an ethical manner, geared towards shareholders’ best interests.

Financial Reports

Analyst Coverage

Acumen Capital Finance Partners, Ltd.

Nick Corcoran

Beacon Securities Unlimited

Doug Cooper

Bloom Burton Securities, Inc.

Prasath Pandurangan

Lake Street Capital Markets

Brooks O’Neil

RBC Capital Markets

Regulatory Filings

Viemed’s public filings, including news releases, financial reports, management proxy circulars, and annual information forms, are available from The System for Electronic Document Analysis and Retrieval (SEDAR), an electronic filing system for Canadian publicly traded companies and the electronic data gathering, analysis and retrieval (EDGAR), an electronic filing system for US listed companies.

Stock Information

Sign Up Here for an Investor Pack and Information

If you would like to receive a corporate information package or for someone to contact you directly, please complete the form below, and we will get back to you shortly:

Investor Contacts

Investor Relations

Glen Akselrod

Bristol Capital IR

[email protected]

905-326-1888

Corporate

Todd Zehnder

Chief Operating Officer

VieMed

[email protected]

337-504-3802

Ticker Symbol

The Company’s common shares are traded in the U.S. on the Nasdaq Capital Market under the symbol "VMD" and in Canada on the Toronto Stock Exchange under the symbol "VMD.TO"

Transfer Agent & Registrar

Computershare Investor Services Inc.
2nd Floor, 510 Burrard Street,
Vancouver, British Columbia V6C 3A8.

Auditor

Ernst & Young LLP

701 Poydras Street, Suite 3900,

New Orleans, LA 70139